↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$1.3MSold on the market
1Companies
Sep 17, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 202616:28 | Sep 15, 2026 | VERAVera Therapeutics, Inc. | PRESIDENT AND CEO, Director | S · Sell10b5-1 | $37.00 | −18,500 | 235,244 | -7% | −$685K | ||
| Sep 17, 202616:28 | Sep 15, 2026 | VERAVera Therapeutics, Inc. | PRESIDENT AND CEO, Director | M · Exercise10b5-1 | $2.90 | +18,500 | 253,744 | +8% | $54K | ||
| Sep 4, 202616:15 | Sep 2, 2026 | VERAVera Therapeutics, Inc. | PRESIDENT AND CEO, Director | S · Sell10b5-1 | $35.12 | −18,500 | 235,244 | -7% | −$650K | ||
| Sep 4, 202616:15 | Sep 2, 2026 | VERAVera Therapeutics, Inc. | PRESIDENT AND CEO, Director | M · Exercise10b5-1 | $2.90 | +18,500 | 253,744 | +8% | $54K |